傻瓜
发表于 2025-3-26 21:58:34
Recurrent and De Novo Diseases After Renal Transplantationressive medications led to an improvement in long-term allograft survival rates. As transplant outcomes improved, recurrent and de novo diseases have assumed greater importance as a cause of renal allograft dysfunction and failure. This chapter will discuss recurrent and de novo diseases following kidney transplant.
缺乏
发表于 2025-3-27 01:52:11
http://reply.papertrans.cn/55/5427/542687/542687_32.png
我没有强迫
发表于 2025-3-27 06:08:20
http://reply.papertrans.cn/55/5427/542687/542687_33.png
腐烂
发表于 2025-3-27 11:12:56
http://reply.papertrans.cn/55/5427/542687/542687_34.png
Glucose
发表于 2025-3-27 16:43:23
http://reply.papertrans.cn/55/5427/542687/542687_35.png
别炫耀
发表于 2025-3-27 19:08:38
Surgical Issues in the Transplant Recipientransplantation surgical issues is detailed with special emphasis on surgical technique. We also discuss acute illness in the transplant recipient that require surgical consultation such as gastrointestinal hemorrhage, acute abdominal pain and describe current guidelines in their evaluation and management.
hedonic
发表于 2025-3-27 21:58:43
Evaluation and Initial Management of Graft Dysfunctionf kidney transplant dysfunction and offer a framework for assessment and management in a stepwise manner. Many of the specific causes of graft dysfunction are discussed in greater detail in accompanying chapters, and the reader is directed to these chapters when applicable.
misshapen
发表于 2025-3-28 04:13:39
Psychosocial Issues in Renal Transplantationransplant candidate. Despite transplanting the ideal donor kidney into a healthy recipient, long-term success is not assured. There are a myriad of psychosocial factors which can alter the path to long-term success.
精致
发表于 2025-3-28 07:45:22
http://reply.papertrans.cn/55/5427/542687/542687_39.png
APNEA
发表于 2025-3-28 14:24:28
Immunological Assessment of the Transplant Patientsion begins with the various immunologic barriers to transplantation, including ABO blood group differences, circulating anti-donor human leukocyte antigen (HLA) antibodies from previous antigen exposure, and minor histocompatibility antigens, which is why even HLA-identical siblings require at leas